Combinations With Abemaciclib Show Long-Term Disease Control in Advanced Breast Cancer
October 19th 2016Abemaciclib plus tamoxifen, trastuzumab, or one of many endocrine-based therapies demonstrated significant antitumor activity and clinical benefit in patients with advanced breast cancer.
Read More